160 related articles for article (PubMed ID: 30903272)
1. Robust expression of EZH2 in endocervical neoplastic lesions.
Makk E; Bálint L; Cifra J; Tornóczky T; Oszter A; Tóth A; Kálmán E; Kovács K
Virchows Arch; 2019 Jul; 475(1):95-104. PubMed ID: 30903272
[TBL] [Abstract][Full Text] [Related]
2. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of p53 and bcl-2 proteins in neoplastic and non-neoplastic endocervical glandular lesions.
McCluggage G; McBride H; Maxwell P; Bharucha H
Int J Gynecol Pathol; 1997 Jan; 16(1):22-7. PubMed ID: 8986528
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 immunoreactivity in normal endocervix and diagnostic value in reactive and neoplastic endocervical lesions.
Little L; Stewart CJ
Mod Pathol; 2010 Apr; 23(4):611-8. PubMed ID: 20062011
[TBL] [Abstract][Full Text] [Related]
5. The expression of epithelial specific antigen in cervical intraepithelial neoplasia and adenocarcinoma.
Markaki S; Lazaris D; Papaspirou I; Paulou V
Eur J Gynaecol Oncol; 2004; 25(1):101-3. PubMed ID: 15053074
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value and implications of vimentin expression in normal, reactive and neoplastic endocervical epithelium.
Stewart CJ; Little L
Pathology; 2010 Apr; 42(3):217-23. PubMed ID: 20350213
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis, proliferation, and expression of p53 and bcl-2 in endocervical glandular intraepithelial lesions and invasive endocervical adenocarcinoma.
Ali-Fehmi R; Qureshi F; Lawrence WD; Jacques SM
Int J Gynecol Pathol; 2004 Jan; 23(1):1-6. PubMed ID: 14668542
[TBL] [Abstract][Full Text] [Related]
8. Distribution of epithelial-specific antigen in uterine cervix with endocervical glandular dysplasia.
Umezaki K; Sanezumi M; Okada H; Okamura A; Tsubra A; Kanazaki H
Gynecol Oncol; 1997 Sep; 66(3):393-8. PubMed ID: 9299251
[TBL] [Abstract][Full Text] [Related]
9. A pilot evaluation of a novel immunohistochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression (ProEx C) in cervical adenocarcinoma in situ, adenocarcinoma, and benign glandular mimics.
Aximu D; Azad A; Ni R; Colgan T; Nanji S
Int J Gynecol Pathol; 2009 Mar; 28(2):114-9. PubMed ID: 19188825
[TBL] [Abstract][Full Text] [Related]
10. Gastric-type adenocarcinoma in situ of uterine cervix: cytological and histopathological features of two cases.
Yuan CT; Lin MC; Kuo KT; Wang TH; Mao TL
Virchows Arch; 2016 Sep; 469(3):351-6. PubMed ID: 27334141
[TBL] [Abstract][Full Text] [Related]
11. Superficial (early) endocervical adenocarcinoma in situ: a study of 12 cases and comparison to conventional AIS.
Witkiewicz A; Lee KR; Brodsky G; Cviko A; Brodsky J; Crum CP
Am J Surg Pathol; 2005 Dec; 29(12):1609-14. PubMed ID: 16327433
[TBL] [Abstract][Full Text] [Related]
12. Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
Asaka S; Nakajima T; Momose M; Miyamoto T; Uehara T; Ota H
Virchows Arch; 2019 Jan; 474(1):79-86. PubMed ID: 30324235
[TBL] [Abstract][Full Text] [Related]
13. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
14. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
Liao SY; Stanbridge EJ
Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
[TBL] [Abstract][Full Text] [Related]
15. Endocervical adenocarcinoma in situ-from Papanicolaou test to hysterectomy: a series of 74 cases.
Lashmanova N; Braun A; Cheng L; Gattuso P; Yan L
J Am Soc Cytopathol; 2022; 11(1):13-20. PubMed ID: 34509373
[TBL] [Abstract][Full Text] [Related]
16. Cytology and curetting diagnosis of endocervical adenocarcinoma.
Bruehl FK; Dyhdalo KS; Hou Y; Clapacs E; Przybycin CG; Reynolds JP
J Am Soc Cytopathol; 2020; 9(6):556-562. PubMed ID: 32624383
[TBL] [Abstract][Full Text] [Related]
17. Keratin 17 Is a Prognostic Biomarker in Endocervical Glandular Neoplasia.
Mockler D; Escobar-Hoyos LF; Akalin A; Romeiser J; Shroyer AL; Shroyer KR
Am J Clin Pathol; 2017 Sep; 148(3):264-273. PubMed ID: 28821199
[TBL] [Abstract][Full Text] [Related]
18. Mucinous expression in benign and neoplastic glandular lesions of the uterine cervix.
Baker AC; Eltoum I; Curry RO; Stockard CR; Manne U; Grizzle WE; Chhieng D
Arch Pathol Lab Med; 2006 Oct; 130(10):1510-5. PubMed ID: 17090193
[TBL] [Abstract][Full Text] [Related]
19. p16 is superior to Stathmin-1 and HSP27 in identifying cervical dysplasia.
Liou S; Nilforoushan N; Kang Y; Moatamed NA
Diagn Pathol; 2021 Sep; 16(1):85. PubMed ID: 34544445
[TBL] [Abstract][Full Text] [Related]
20. Mitotic activity and apoptosis in endocervical glandular lesions.
Moritani S; Ioffe OB; Sagae S; Dahmoush L; Silverberg SG; Hattori T
Int J Gynecol Pathol; 2002 Apr; 21(2):125-33. PubMed ID: 11917221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
